Literature DB >> 19058317

Complete hepatocellular carcinoma necrosis following sequential porto-arterial embolization.

Stéphane Zalinski1, Olivier Scatton, Bruto Randone, Olivier Vignaux, Bertrand Dousset.   

Abstract

Most patients with hepatocellular carcinoma (HCC) are not eligible for curative treatment, which is resection or transplantation. Two recent series have emphasized the potential benefits of preoperative arterio-portal embolization prior to surgical resection of such tumours. This preoperative strategy offers a better disease free survival rate and a higher rate of total tumor necrosis. In case of non resectable HCC it is now widely accepted that transarterial chemoembolization (TACE) leads to a better survival when compared to conservative treatment. Thus, the question remains whether combined portal vein embolization (PVE) may enhance the proven efficiency of TACE in patients with unresectable HCC. We herein report the case of a 56-year-old cirrhotic woman with a voluminous HCC unsuitable for surgical resection. Yet, complete tumour necrosis and prolonged survival could be achieved after a combined porto-arterial embolization. This case emphasizes the potential synergistic effect of a combined arterio-portal embolization and the hypothetical survival benefit of such a procedure, in selected patients, with HCC not suitable for surgery or local ablative therapy.

Entities:  

Mesh:

Year:  2008        PMID: 19058317      PMCID: PMC2773886          DOI: 10.3748/wjg.14.6869

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  25 in total

1.  The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.

Authors:  Z Zhang; Q Liu; J He; J Yang; G Yang; M Wu
Journal:  Cancer       Date:  2000-12-15       Impact factor: 6.860

Review 2.  Prognostic prediction and treatment strategy in hepatocellular carcinoma.

Authors:  Jordi Bruix; Josep M Llovet
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

3.  Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma.

Authors:  S Ogata; J Belghiti; O Farges; D Varma; A Sibert; V Vilgrain
Journal:  Br J Surg       Date:  2006-09       Impact factor: 6.939

4.  Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial.

Authors:  Josep M Llovet; Maria Isabel Real; Xavier Montaña; Ramon Planas; Susana Coll; John Aponte; Carmen Ayuso; Margarita Sala; Jordi Muchart; Ricard Solà; Joan Rodés; Jordi Bruix
Journal:  Lancet       Date:  2002-05-18       Impact factor: 79.321

Review 5.  Methods and related drawbacks in the estimation of surgical risks in cirrhotic patients undergoing hepatectomy.

Authors:  Sheung-Tat Fan
Journal:  Hepatogastroenterology       Date:  2002 Jan-Feb

6.  Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma.

Authors:  Taku Aoki; Hiroshi Imamura; Kiyoshi Hasegawa; Akira Matsukura; Keiji Sano; Yasuhiko Sugawara; Norihiro Kokudo; Masatoshi Makuuchi
Journal:  Arch Surg       Date:  2004-07

Review 7.  Hepatocellular carcinoma.

Authors:  Josep M Llovet; Andrew Burroughs; Jordi Bruix
Journal:  Lancet       Date:  2003-12-06       Impact factor: 79.321

8.  IHPBA concordant classification of primary liver cancer: working group report.

Authors:  Masatoshi Makuuchi; Jacques Belghiti; Giulio Belli; Sheung-Tat Fan; Joseph Wan Yee Lau; Burckhardt Ringe; Steven Martin Strasberg; Jean-Nicolas Vauthey; Yoshio Yamaoka; Susumu Yamasaki
Journal:  J Hepatobiliary Pancreat Surg       Date:  2003

Review 9.  Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.

Authors:  Calogero Cammà; Filippo Schepis; Ambrogio Orlando; Maddalena Albanese; Lillian Shahied; Franco Trevisani; Pietro Andreone; Antonio Craxì; Mario Cottone
Journal:  Radiology       Date:  2002-07       Impact factor: 11.105

Review 10.  Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival.

Authors:  Josep M Llovet; Jordi Bruix
Journal:  Hepatology       Date:  2003-02       Impact factor: 17.425

View more
  4 in total

1.  Necrosis of large hepatocellular carcinoma induced by preoperative portal vein embolization: a case report.

Authors:  Akira Yasuda; Tsuyoshi Kurokawa; Noiku Nakao; Hiroyuki Fujisaki; Keiichi Ando; Nobuhiro Ito; Norifumi Ohashi; Takashi Arikawa; Takahisa Tainaka; Hiroshi Nagata; Kazuyoshi Suzumura; Toshiaki Nonami
Journal:  Dig Dis Sci       Date:  2013-04-16       Impact factor: 3.199

Review 2.  Combination of transcatheter arterial chemoembolization and portal vein embolization for patients with hepatocellular carcinoma: a review.

Authors:  Zhiying Shao; Xin Liu; Chanjuan Peng; Liping Wang; Dong Xu
Journal:  World J Surg Oncol       Date:  2021-10-01       Impact factor: 2.754

3.  Change of tumor-infiltrating lymphocyte of associating liver partition and portal vein ligation for staged hepatectomy for hepatocellular carcinoma.

Authors:  Wei Wang; Zhen-Feng Deng; Ji-Long Wang; Ling Zhang; Li Bao; Bang-Hao Xu; Hai Zhu; Ya Guo; Zhang Wen
Journal:  World J Gastrointest Surg       Date:  2022-09-27

4.  Feasibility and Safety of Delayed Catheter Removal Technique in Percutaneous Trans-Hepatic Portal Vein Embolization.

Authors:  Chengjian He; Naijian Ge; Yefa Yang
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.